% | $
Quotes you view appear here for quick access.

Isis Pharmaceuticals, Inc. Message Board

  • dinepat203 dinepat203 Nov 16, 2012 2:03 PM Flag

    $15 BY JAN 2013 ?

    Safety and Efficacy of ISIS 301012 (Mipomersen) As Add-on Therapy in High Risk Hypercholesterolemic Patients

    Based on this reviewer’s own parametric (including SAS Generalized Linear
    Model program) and nonparametric (Wilcoxon’s two-sample test) analyses and
    the sponsor’s results, efficacy results are highly significant showing the efficacy
    of mipomersen with respect to LDL-C over 26 weeks (p

    Sentiment: Strong Buy

42.440.00(0.00%)3:59 PMEDT